维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="PRUDKIN L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER-2 receptor显示文摘	Scaltriti M Chandarlapaty S Prudkin L		0，，：	1
2	Epithelial-to-mesenchymal tran- sition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung 显示文摘	Prudkin L Liu D Ozburn NC	2009	Mod Pathol2009，22，5：	1
3	Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation显示文摘	Raso MG Behrens C Herynk MH Liu S Prudkin L Ozburn NC	2009	Clin Cancer Res2009，15，17：	1
4	Germ-line and somatic pre- sentations of the EGFR T790M mutation in lung cancer显示文摘	Prudkin L Tang X Wistuba II	2009	J Thorac Oncol2009，4，1：	1
5	Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung显示文摘	Prudkin L Liu DD Ozburn NC	2009	Mod Pathol2009，22，5：	1
6	Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects显示文摘	Ivanova AV Ivanov SV Prudkin L	2009	Mol Cancer2009，8，1：	1
7	PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer显示文摘	Serra V Scaltriti M Prudkin L	2011	Oncogene2011，30，22：	1
8	PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2 - overexpressing breast cancer 显示文摘	Serra V Scaltriti M Prudkin L	2011	Oncogene2011，30，22：	1
9	A petide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer 显示文摘	Elayadi AN Samli KN Prudkin L	2007	Cancer Res2007，67，2007：	1
10	A peptide selected by bioparming identifies the integrin αvβ6 as a prognostic biomarker for non-small cell lung cancer显示文摘	ELAYADI AN SAMLI KN PRUDKIN L	2007	Cancer Res2007，67，：	1
11	PI3K inhibition results in enhanced HER Signaling and acquired ERK dependency in HER2-over-expressing breast cancer显示文摘	Serra V Scaltriti L Prudkin	2011	Oncogene2011，30，：	1
12	Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung 显示文摘	Prudkin L Liu D D Ozburn N C	2009	Mod Pathol2009，22，5：	1
13	Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer显示文摘	Brannan JM Dong W Prudkin L	2009	Clin Cancer Res2009，15，13：	1
14	PI3K inhibition results in en- hanced HER signaling and acquired ERK dependency in HER2-over- expressing breast cancer 显示文摘	Serra V Scahriti M Prudkin L		Oncogen0，30，22：	1
15	A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer显示文摘	Elayadi A N Samli K N Prudkin L	2007	Cancer Res2007，67，12：	1
16	Epithelial-tomesenchymal transition in the development and progression of adenoearcinoma and squamous cell carcinoma of the lung显示文摘	PRUDKIN L LIU D D OZBURN N C	2009	Mod Pathol2009，22，5：	1
17	Epithelial-to-mesenchymal transition in the development and progression of adenocarci- noma and squamous cell carcinoma of the lung 显示文摘	Prudkin L Liu DD Ozburn NC	2009	Mod Pathol2009，22，5：	1
18	PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2 - overexpressing breast cancer 显示文摘	Serra V Scaltriti M Prudkin L	2011	Oncogene2011，30，22：	1
19	Clinical benefit of lapatinib-based therapy in patients with HER2-positive breast tumors co-expressing the truncated p95HER2 recept显示文摘	Scaltriti M Chandarlapaty S Prudkin L	2010	Clin Cancer Res2010，16，9：	1
20	PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer显示文摘	Serra V Scaltriti M Prudkin L	2011	Oncogene2011，30，22：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示